Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Nonmelanoma Skin Cancers
Interventions
OTHER

have Levulan Kerastick (aminolevulinic acid) solution

Levulan Kerastick (aminolevulinic acid) solution applied to the face and/or scalp (if both are needed, treated separately on back to back days); with an incubation period of 2.5 hours. Blue light photodynamic therapy utilizing the DUSA BLU-U device, illumination: 1000 seconds (16 min, 40 secs), will be administered

Trial Locations (1)

22031

Inova Melanoma Na Skin Oncology Center, Fairfax

Sponsors
All Listed Sponsors
collaborator

DUSA Pharmaceuticals, Inc.

INDUSTRY

lead

Inova Health Care Services

OTHER